BIOHAL - Medical Ecosystem with the decentralized biometrics authentication protocol for the secured and encrypted liquid biopsy data. Biohal's mission is to create a universally available preventive medicine platform that runs on blockchain with liquid biopsy protocol. By joining hands with PROTEO, the first liquid biopsy research partner, Biohal can detect cancer and alzheimers at early stages. With minimally invasive markers, Biohal's test accuracy remains at 99%.
We strongly hope to reduce ballooning medical expenses in the world, eliminate the need for nursing care and make a world free of severe diseases by building the BIOHAL platform with DNA biometric authentication as the core and establishing the ecosystem to change the existing medical system.
The BIOHAL platform can be used as a medical data center. By allowing patients, doctors, hospitals, pharmaceutical companies and medical device manufacturers to safely share the data they have, we can provide an opportunity to receive medical examination to people at the BOP (Base of the Economic Pyramid), who could not afford for preventive medicine, best treatment to patients, accurate diagnostic support to doctors, efficient management solutions to hospitals, and business chances to pharmaceutical companies.